Pharmacokinetics and Safety of a Novel Extended‐Release Microsphere Formulation of Risperidone in Patients with Schizophrenia or Schizoaffective Disorder.

Autor: Walling, David P.1 (AUTHOR), Dong, Ying2 (AUTHOR), Litman, Robert3,4 (AUTHOR), Wang, Wenyan5,6,7 (AUTHOR), Liu, Chunli6,7 (AUTHOR), Tai, Joe2 (AUTHOR), Liu, Pinglan6,7 (AUTHOR), Shi, Yanan5,6 (AUTHOR), Liu, Wanhui5,6,7 (AUTHOR), Fu, Fenghua5,6,7 (AUTHOR), Sun, Kaoxiang5,6,7 (AUTHOR) sunkx@ytu.edu.cn
Zdroj: Journal of Clinical Pharmacology. Oct2024, p1. 10p. 3 Illustrations.
Databáze: Academic Search Ultimate
Externí odkaz: